Pharmaceutical manufacturer Actavis Totowa is recalling more than 65 generic drug products manufactured at its Little Falls, New Jersey, facility. The recall follows an inspection conducted by the Food & Drug Administration earlier this year, which revealed that operations at the New Jersey facility did not meet FDA standards. Actavis has acknowledged that the Little Falls facility does not meet the company’s own standards for good manufacturing practices. As a result, Actavis made the decision to recall products manufactured at that facility at the pharmacy/retail level, including wholesalers and hospitals.

Earlier this year, in April 2008, Actavis Totowa issued a Class I recall of its Digitek product, which is used to treat heart problems. It had been discovered that tablets may have been manufactured at twice their intended thickness, doubling the amount of medication in the pills and putting patients at risk for serious complications as a result of higher dosages than intended. According to the company, there haven’t been any product complaints or negative health incidents reported involving products affected by this new recall. All of the recalled products are prescription medications.

The manufacturer recommends that patients currently taking the affected medications should not stop taking the drugs, as a sudden stop in medication could be dangerous. Patients should consult with their doctor or pharmacist for replacement medication. Actavis Totowa has already issued recall letters to wholesalers and retailers. You can find a list of the recalled drugs on our Web site at www.BeasleyAllen.com or by contacting Chad Cook in our Mass Torts Section at 800-898-2034 or by email at Chad.Cook@BeasleyAllen.com.

Other Related Articles

• Ethex Corporation Recalls Morphine Sulfate Tablets
• Recall Of Heart Failure Medication Digitek
• FDA alerts medical community of new suicide warnings on epilepsy drugs
• More recalls of Digoxin
• FDA Puts Black Box Warning On Bowel-Clearing Drugs